These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 31362244)

  • 21. Curcumin relieves depressive-like behaviors via inhibition of the NLRP3 inflammasome and kynurenine pathway in rats suffering from chronic unpredictable mild stress.
    Zhang WY; Guo YJ; Han WX; Yang MQ; Wen LP; Wang KY; Jiang P
    Int Immunopharmacol; 2019 Feb; 67():138-144. PubMed ID: 30551030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice.
    Xu L; Lin G; Yu Q; Li Q; Mai L; Cheng J; Xie J; Liu Y; Su Z; Li Y
    Front Pharmacol; 2021; 12():645879. PubMed ID: 33959014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypouricemic and Nephroprotective Effects of Emodinol in Oxonate-Induced Hyperuricemic Mice are Mediated by Organic Ion Transporters and OIT3.
    Hui W; Yongliang Y; Yongde C; Guo L; Li L; Zhonglin Y; Hui J; Qinghua H
    Planta Med; 2016 Mar; 82(4):289-297. PubMed ID: 26584455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice.
    Yang Y; Zhang DM; Liu JH; Hu LS; Xue QC; Ding XQ; Kong LD
    J Ethnopharmacol; 2015 Jul; 169():49-59. PubMed ID: 25914040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-hyperuricemic and nephroprotective effects of extracts from Chaenomeles sinensis (Thouin) Koehne in hyperuricemic mice.
    Zhang R; Zhan S; Li S; Zhu Z; He J; Lorenzo JM; Barba FJ
    Food Funct; 2018 Nov; 9(11):5778-5790. PubMed ID: 30327809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoorientin exerts a urate-lowering effect through inhibition of xanthine oxidase and regulation of the TLR4-NLRP3 inflammasome signaling pathway.
    An MF; Wang MY; Shen C; Sun ZR; Zhao YL; Wang XJ; Sheng J
    J Nat Med; 2021 Jan; 75(1):129-141. PubMed ID: 33188510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihyperuricemic effect of liquiritigenin in potassium oxonate-induced hyperuricemic rats.
    Hongyan L; Suling W; Weina Z; Yajie Z; Jie R
    Biomed Pharmacother; 2016 Dec; 84():1930-1936. PubMed ID: 27863839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model.
    Li Q; Huang Z; Liu D; Zheng J; Xie J; Chen J; Zeng H; Su Z; Li Y
    Drug Des Devel Ther; 2021; 15():3241-3254. PubMed ID: 34349501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A flavonoid-rich fraction of Monolluma quadrangula inhibits xanthine oxidase and ameliorates potassium oxonate-induced hyperuricemia in rats.
    ALRashdi BM; Elgebaly HA; Germoush MO; Qarmush MM; Azab MS; Alruhaimi RS; Ahmeda AF; Abukhalil MH; Kamel EM; Arab HH; Alzoghaibi MA; Alotaibi MF; Mahmoud AM
    Environ Sci Pollut Res Int; 2022 Sep; 29(42):63520-63532. PubMed ID: 35461413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlorogenic acid supplementation ameliorates hyperuricemia, relieves renal inflammation, and modulates intestinal homeostasis.
    Zhou X; Zhang B; Zhao X; Lin Y; Wang J; Wang X; Hu N; Wang S
    Food Funct; 2021 Jun; 12(12):5637-5649. PubMed ID: 34018499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-hyperuricemic and nephroprotective effects of Modified Simiao Decoction in hyperuricemic mice.
    Hua J; Huang P; Zhu CM; Yuan X; Yu CH
    J Ethnopharmacol; 2012 Jun; 142(1):248-52. PubMed ID: 22575704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the effects of rare ginsenosides on hyperuricemia and associated sperm damage via nontargeted metabolomics and gut microbiota.
    Ji X; Yu L; Han C; Gao H; Cai Y; Li J; He Y; Lu H; Song G; Xue P
    J Ethnopharmacol; 2024 Oct; 332():118362. PubMed ID: 38768838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats.
    Hu QH; Zhang X; Pan Y; Li YC; Kong LD
    Biochem Pharmacol; 2012 Jul; 84(1):113-25. PubMed ID: 22426011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chloroquine inhibits NLRP3 inflammasomes activation and alleviates renal fibrosis in mouse model of hyperuricemic nephropathy with aggravation by a high-fat-diet.
    Cui J; Hong P; Li Z; Lin J; Wu X; Nie K; Zhang X; Wan J
    Int Immunopharmacol; 2023 Jul; 120():110353. PubMed ID: 37276828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simiao pill inhibits epithelial mesenchymal transition in a mouse model of chronic hyperuricemic nephropathy by inhibiting NLRP3 inflammasome activation.
    Shui G; Cai Z; Wang F; Chen T; Huang X; Cai Y; Mi X
    BMC Complement Med Ther; 2022 Oct; 22(1):278. PubMed ID: 36271349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withaferin A protects against hyperuricemia induced kidney injury and its possible mechanisms.
    Zhao X; Wang J; Tang L; Li P; Ru J; Bai Y
    Bioengineered; 2021 Dec; 12(1):589-600. PubMed ID: 33517833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isorhamnetin, the xanthine oxidase inhibitor from
    Wang F; Zhao X; Su X; Song D; Zou F; Fang L
    Food Funct; 2021 Dec; 12(24):12503-12512. PubMed ID: 34806108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emodinol ameliorates urate nephropathy by regulating renal organic ion transporters and inhibiting immune inflammatory responses in rats.
    Wu H; Zhou M; Lu G; Yang Z; Ji H; Hu Q
    Biomed Pharmacother; 2017 Dec; 96():727-735. PubMed ID: 29045935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine.
    Wu XH; Wang CZ; Wang SQ; Mi C; He Y; Zhang J; Zhang YW; Anderson S; Yuan CS
    J Ethnopharmacol; 2015 Mar; 162():362-8. PubMed ID: 25617746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological Basis for Use of a Novel Compound in Hyperuricemia: Anti-Hyperuricemic and Anti-Inflammatory Effects.
    Zhao L; Li Y; Yao D; Sun R; Liu S; Chen X; Lin C; Huang J; Wang J; Li G
    Front Pharmacol; 2021; 12():772504. PubMed ID: 34819865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.